Penicillin is a family of antibiotics originally obtained from molds of the genus Penicillium, a group of fungi. It belongs to the beta-lactam antibiotics, which share a characteristic four-membered chemical ring. The name can refer collectively to natural and semisynthetic penicillins or, more narrowly, to the original drugs penicillin G and penicillin V. These medicines act against susceptible bacteria by interfering with the construction of their cell walls. Their discovery and development established an important foundation for antibacterial treatment in twentieth-century medicine. (fda.gov)
Discovery and clinical development
In 1928, Alexander Fleming, working at St. Mary’s Hospital in London, observed that a mold contaminating a culture of staphylococci inhibited bacterial growth around it. He investigated the antibacterial substance and named it penicillin, publishing his findings in 1929. The observation did not immediately produce a practical medicine: extracting sufficient quantities of an unstable substance and establishing its therapeutic effects required further research. (acs.org)
At the University of Oxford, Howard Florey, Ernst Boris Chain, Norman Heatley, Edward Abraham, and colleagues developed purification methods and investigated penicillin experimentally. Their work led to clinical treatment in 1941. Early supplies were extremely limited, and producing enough material for sustained treatment became a major scientific and industrial challenge. (acs.org)
During World War II, British and American researchers, government laboratories, and pharmaceutical manufacturers expanded production. Improved mold strains, growth media, and submerged fermentation made substantially larger supplies possible. In 1945, Fleming, Chain, and Florey jointly received the Nobel Prize in Physiology or Medicine for the discovery of penicillin and its therapeutic effects in infectious diseases. (acs.org)
Chemical structure and mechanism
Penicillins have a beta-lactam ring fused to a five-membered sulfur-containing thiazolidine ring. Differences in the attached side chain distinguish individual members of the family. The shared ring system is essential to their antibacterial activity. (fda.gov)
Their principal targets are penicillin-binding proteins, bacterial enzymes involved in building and maintaining peptidoglycan. This material forms a mesh-like structural layer in the bacterial cell wall. Penicillins form a covalent bond with the active site of susceptible target proteins, inhibiting the cross-linking reactions that strengthen the wall. Disruption of these processes can cause bacterial death, particularly during active growth. (pmc.ncbi.nlm.nih.gov)
This mechanism distinguishes penicillins from antibiotics that inhibit protein synthesis or nucleic-acid processes. Their effectiveness nevertheless depends on the organism’s susceptibility, access of the drug to its targets, and the presence of resistance mechanisms; belonging to the same chemical family does not give every penicillin an identical antibacterial spectrum. (pmc.ncbi.nlm.nih.gov)
Principal forms and derivatives
Penicillin G, also called benzylpenicillin, is used in injectable preparations. Its sodium and potassium salts provide relatively rapid systemic exposure. Other formulations have different release characteristics, so the chemical name alone does not fully identify a preparation’s clinical properties. (dailymed.nlm.nih.gov)
Penicillin V, or phenoxymethylpenicillin, is more resistant than penicillin G to inactivation by gastric acid and is available for oral administration. Both drugs inhibit susceptible bacteria, but neither is reliably active against organisms producing penicillinase. (dailymed.nlm.nih.gov)
Semisynthetic penicillins retain the penicillin nucleus while incorporating chemical modifications. Amoxicillin is one such antibacterial drug. Nafcillin is a penicillinase-resistant derivative used against susceptible penicillinase-producing staphylococci; this resistance to an enzyme does not make it effective against methicillin-resistant staphylococci. (dailymed.nlm.nih.gov)
Some preparations combine a penicillin with a beta-lactamase inhibitor. Examples include ampicillin–sulbactam and piperacillin–tazobactam. These combinations counter certain bacterial enzymes that would otherwise inactivate the antibiotic, but they do not overcome every mechanism of resistance. (accessdata.fda.gov)
Clinical applications and disposition
Penicillin G and penicillin V have established roles in treating particular infectious diseases caused by susceptible organisms, including some streptococcal infections. Penicillin G also has a central role in treating syphilis, caused by Treponema pallidum. The formulation used depends on the disease’s stage and manifestations. CDC guidance identifies parenteral penicillin G as the only therapy with documented efficacy for syphilis during pregnancy. (dailymed.nlm.nih.gov)
Penicillin G is eliminated predominantly through the kidneys, and impaired kidney function can prolong its persistence in the bloodstream. Distribution into cerebrospinal fluid is limited under ordinary conditions but increases when the meninges are inflamed. These pharmacological properties help explain why route of administration and formulation are important distinctions between preparations. (dailymed.nlm.nih.gov)
Resistance and adverse effects
Antibiotic resistance to penicillins has several biological mechanisms. Beta-lactamases can inactivate the drug through hydrolysis of its beta-lactam ring. Altered penicillin-binding proteins can reduce binding, while changes in bacterial permeability or drug efflux can limit the amount reaching its targets. Consequently, susceptibility cannot be inferred solely from a bacterium’s broad taxonomic group. (pmc.ncbi.nlm.nih.gov)
Adverse effects include gastrointestinal symptoms, rashes, and allergic reactions, including potentially life-threatening anaphylaxis. High systemic exposure to penicillin G can produce neurological toxicity, particularly in people with impaired renal function. Its potassium-containing preparations can also cause electrolyte disturbances when administered in large quantities. (dailymed.nlm.nih.gov)
A recorded penicillin allergy is not equivalent to a confirmed allergy. CDC guidance describes substantial overreporting and distinguishes immune-mediated hypersensitivity from intolerance and other reactions. Clinical evaluation may involve a detailed history, skin testing, and supervised drug challenge. Separately, the febrile Jarisch–Herxheimer reaction following syphilis treatment is a treatment-associated reaction, not an allergic reaction to penicillin. (cdc.gov)